Corvus Pharmaceuticals (CRVS) Stock Price
$5.9 0.3%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
6 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Corvus Pharmaceuticals, AI stock picks, stock alerts and much more.
CRVS AI Stock Analysis
AI stock analysis for CRVS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Corvus Pharmaceuticals (CRVS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Corvus Pharmaceuticals (CRVS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Corvus Pharmaceuticals (CRVS), currently trading at $5.9, will... Sign up to access price prediction.
About CRVS
-
Corvus Pharmaceuticals, Inc.
-
Symbol
CRVS
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
439.6M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.94 0.9% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.31 1.1% |
2 |
 |
Moderna MRNA |
$25.28 5.9% |
4 |
 |
Anavex Life Sciences AVXL |
$9.16 0.8% |
5 |
 |
BridgeBio Pharma BBIO |
$51.26 0.4% |
6 |
News
CRVS Alternative Data
Web Traffic
Corvus Pharmaceuticals receives an estimated 19121 monthly visitors to corvuspharma.com.
-
Web Traffic
19121
-
Change from Previous Month
1%
-
3 Month Change
23.8%
-
YoY Change
23.8%
LinkedIn Followers
7,180 are following Corvus Pharmaceuticals on LinkedIn, up by 1.6% over the last month.
-
LinkedIn Followers
7180
-
Daily Change
0%
-
1 Month Change
1.6%
-
3 Month Change
3%
-
YoY Change
3%
Job Postings
Corvus Pharmaceuticals currenly has an estimated 2 open job postings.
-
Job Postings
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Corvus Pharmaceuticals has 43 employees.
-
LinkedIn Employees
43
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
4.9%
-
YoY Change
4.9%
Reddit Mentions
Corvus Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Corvus Pharmaceuticals is 58 out of 100 (neutral).
-
Business Outlook
58
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Corvus Pharmaceuticals was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
CRVS Financials
CRVS Key Metrics
-
Total Revenue
$0
-
Net Income
-$12.1M
-
Earnings per Share
-$0.2
-
Free cash flow
-$8.5M
-
EBITDA
-$8.1M
-
EBITDA Ratio
0
-
Total Assets
$68.9M
CRVS 2-year Revenue & Income
CRVS 2-year Free Cash Flow
CRVS Technicals
CRVS SMA
CRVS RSI
FAQ
What's the current price of Corvus Pharmaceuticals (CRVS) Stock?
The price of an Corvus Pharmaceuticals (CRVS) share is $5.9.
What's the market cap of Corvus Pharmaceuticals?
The current market cap of Corvus Pharmaceuticals is 439.6M.
What are some stocks similar to Corvus Pharmaceuticals (CRVS) that investors often compare it to?
Corvus Pharmaceuticals (CRVS) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Corvus Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Corvus Pharmaceuticals' stock price to be around $6.12 in 2026. Starting from the current price of $5.9, this represents a 3.7% change in price, indicating a neutral outlook for the stock.
How to buy Corvus Pharmaceuticals (CRVS) Stock?
Corvus Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Corvus Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.